Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

Completed · Phase 3

Conditions studied: Vascular Dementia

In brief

The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.

Key facts

Study ID

NCT00099216

Run by

Novartis Pharmaceuticals

People needed

708

Starts

2001-08-01

Expected to finish

2005-11-01

Last updated by the study team

2011-11-17

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Between the ages of 50 and 85 years old
• Have contact with a responsible caregiver 3 or more days per week
• Be male or a female who is surgically sterilized or one year post menopausal

You may not qualify if…

• Current diagnosis of severe or unstable cardiovascular or other diseases
• Current diagnosis of active, uncontrolled seizure disorder, Parkinson's disease or Alzheimer's disease

Where it is running

• Study site — San Francisco, California, United States
• Study site — Boynton Beach, Florida, United States
• Study site — Miami Beach, Florida, United States
• Study site — Port Charlotte, Florida, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Des Moines, Iowa, United States
• Study site — St Louis, Missouri, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — New York, New York, United States
• Study site — Portland, Oregon, United States
• Study site — Allentown, Pennsylvania, United States
• Study site — Greensburg, Pennsylvania, United States
• Study site — Charleston, South Carolina, United States
• Study site — Austin, Texas, United States
• Study site — Houston, Texas, United States
• Study site — Bennington, Vermont, United States
• Study site — Graz, Austria
• Study site — Linz, Austria
• Study site — Vienna, Austria
• Study site — Edmonton, Alberta, Canada
• Study site — Ottawa, Ontario, Canada
• Study site — Toronto, Ontario, Canada
• Study site — Montreal, Quebec, Canada
• Study site — Amiens, France
• Study site — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.